Cargando…
Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway
Panel-based next generation sequencing (NGS) is currently preferred over whole exome sequencing (WES) for diagnosis of familial breast cancer, due to interpretation challenges caused by variants of uncertain clinical significance (VUS). There is also no consensus on the selection criteria for WES. I...
Autores principales: | van der Merwe, Nicole, Peeters, Armand V., Pienaar, Fredrieka M., Bezuidenhout, Juanita, van Rensburg, Susan J., Kotze, Maritha J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343999/ https://www.ncbi.nlm.nih.gov/pubmed/28241424 http://dx.doi.org/10.3390/ijms18020467 |
Ejemplares similares
-
Identification of an iron-responsive subtype in two children diagnosed with relapsing-remitting multiple sclerosis using whole exome sequencing
por: van Rensburg, Susan J., et al.
Publicado: (2019) -
Pioneering BRCA1/2 Point-Of-Care Testing for Integration of Germline and Tumor Genetics in Breast Cancer Risk Management: A Vision for the Future of Translational Pharmacogenomics
por: Mampunye, Lwando, et al.
Publicado: (2021) -
Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing
por: Torrorey-Sawe, Rispah, et al.
Publicado: (2020) -
Exome sequencing combined with semantic discovery identifies strong disease-associated candidates in a single case of relapsing remitting multiple sclerosis
por: Jalali Sefid Dashti, Mahjoubeh, et al.
Publicado: (2012) -
CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application
por: van der Merwe, Nicole, et al.
Publicado: (2012)